Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Direct MT vs IVT+MT in Anterior Circulation LVO Stroke
NCT03469206Completed
- Sponsor
- Changhai Hospital
- Start
- Feb 2018
- Primary completion
- Oct 2019
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Randomised, open-label trial of tissue-plasminogen activator in ischemic stroke (2 arms), sponsored by Changhai Hospital. Primary endpoint: modified Rankin Scale at 90 days. Started Feb 2018; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03469206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03469206.